Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/22 08:35 | 3/15/22 | PLXP | Health | Drug | Pharmaceutical Preparations | Giordano Natasha | NJ | DO | CEO | P | 15 | 3.65 | 0 | 4 | 378 | 5 | D | ||||||||||||||
3/16/22 08:33 | 3/15/22 | PLXP | Health | Drug | Pharmaceutical Preparations | O'Connor Rita M | NJ | O | CFO | P | 50 | 3.66 | 0 | 14 | 106 | 27 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |